Don’t Jump to Voquezna for Erosive GERD

January 2024

Rx vonoprazan (Voquezna) will be touted as the first acid suppressant with a new mechanism of action in over 30 years.

It’s the first potassium-competitive acid blocker (PCAB)...and is now approved for erosive esophagitis.

Think of vonoprazan as a “fancy PPI”...with some differences.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Contraceptives Prepare for Opill, the First OTC Oral Contraceptive
Obesity & Weight Loss Consider Pros and Cons of Zepbound or Wegovy for Obesity
Infectious Diseases Sort Through Antimicrobial Myths
Substance Use Disorder Manage Meds to Treat Alcohol Use Disorder
Insulin Be Ready to Help Patients Switch Insulin
Gastroenterology Don’t Jump to Voquezna for Erosive GERD
Antipsychotics Focus on Safety With Long-Acting Injectable Antipsychotics
NatMed Spotlight Give Guidance About Coenzyme Q10